Copper-Associated Hepatopathy: Liver Welfare in Dogs

Key Welfare Facts

Copper-associated hepatopathy results from abnormal copper accumulation in the liver causing progressive hepatocellular damage.
Bedlington Terriers have a well-characterised heritable form, but Dobermanns and Labradors are also at risk.
Affected dogs may be asymptomatic until severe liver damage occurs, making early screening critical.
Liver biopsy with quantitative copper determination is required for definitive diagnosis and treatment monitoring.
D-penicillamine chelation therapy reduces hepatic copper and has been shown to improve liver histopathology.
Dietary copper restriction combined with zinc supplementation reduces hepatic copper accumulation as maintenance.

Welfare Assessment

Copper-associated hepatopathy causes progressive, often silent liver damage that is largely preventable in at-risk breeds through early detection and management. Screening at-risk breeds and committing to long-term dietary and medical management protects liver function and welfare.

What You Can Do

Screen at-risk breeds including Bedlington Terriers and Dobermanns with liver biopsies from young adulthood
Discuss copper chelation therapy with a hepatologist or internal medicine specialist after diagnosis
Implement low-copper dietary management as long-term maintenance alongside treatment
Commit to regular monitoring biopsies to track treatment response and guide dose adjustments